Lucile Serfass

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists.

Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists.

Journal: Urology practice

Published: November 07, 2024

Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology.

Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology.

Journal: European urology focus

Published: April 10, 2024

Application of artificial intelligence to overcome clinical information overload in urological cancer.

Application of artificial intelligence to overcome clinical information overload in urological cancer.

Journal: BJU international

Published: November 30, 2021

Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration.

Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration.

Journal: Cancer medicine

Published: July 23, 2021

Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score.

Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score.

Journal: Clinical genitourinary cancer

Published: December 11, 2019

Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysis.

Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysis.

Journal: Future oncology (London, England)

Published: April 24, 2019

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 10, 2018

Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group.

Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group.

Journal: Clinical genitourinary cancer

Published: February 20, 2018

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.

Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.

Journal: European urology

Published: June 14, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026